Investors
0 investorsAll
Early stage
Mid stage
Late stage
No investors in this category
Bioviida Venture Studio develops rare disease drugs through clinical POC. We are actively seeking to in-license therapeutics with the following characteristics:
Indication: Rare diseases (no CNS)
Modality: Small molecules, antibodies, peptides, or proteins
Stage: Lead Candidate or later (in vivo POC data in relevant disease model)
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Find investors for your startup like Bioviida Venture Studio
Gritt sends AI-personalised outreach to each investor — from your Gmail